Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
−Removed: Our common stock is traded on the Nasdaq Stock Market LLC under the symbol “BRKS.”
+Added: Our common stock is traded on the Nasdaq Stock Market LLC, or Nasdaq under the symbol “BRKS.” As of December 1, 2021, our common stock will trade on the Nasdaq under the symbol “AZTA”.
Number of Holders
3 unchanged sentences
Future dividend declarations, as well as the record and payment dates for such dividends, will be determined by our Board of Directors on a quarterly basis.
−Removed: We intend to pay quarterly cash dividends in the future;
−Removed: however, the amount and timing of these dividends may be impacted by the cyclical nature of certain markets we serve.
−Removed: We may reduce, delay or cancel a quarterly cash dividend based on the severity of a cyclical downturn.
+Added: On November 16, 2021 at our investor day conference, we disclosed that we intend to discontinue paying a quarterly dividend upon the completion of the sale of our semiconductor automation business.
On November 2, 2021, our Board of Directors approved a cash dividend of $0.10 per share payable on December 23, 2021 to common stockholders of record on December 3, 2021.
3 unchanged sentences
and (iii) a peer group for the fiscal year ended September 30, 2021 (“Peer Group”).
−Removed: The Peer Group for the year ended September 30, 2020 is comprised of Advanced Energy Industries, Inc., Axcelis Technologies Inc., Bio Rad Laboratories Inc., Bruker Corp., Cabot Microelectronics Corp., Coherent Inc., Entegris, Inc., Formfactor Inc., Haemonetics Corp., MKS Instruments, Inc., MTS Instruments, Inc., Novanta Inc., Onto Innovation Inc., Ultra Clean Holdings, Inc., Varex Imaging Corp.
+Added: The Peer Group for the year ended September 30, 2021 is comprised of Advanced Energy Industries, Inc., Axcelis Technologies Inc., Bio Rad Laboratories Inc., Bruker Corp., Cabot Microelectronics Corp., Coherent Inc., Entegris, Inc., Formfactor Inc., Haemonetics Corp., MKS Instruments, Inc., Novanta Inc., Onto Innovation Inc., Ultra Clean Holdings, Inc., Varex Imaging Corp.
and Veeco Instruments Inc.
8 unchanged sentences
There were no shares repurchased under this program during the fiscal year ended September 30, 2021.
−Removed: Selected Financial Data
−Removed: The selected consolidated financial data (1)(4) set forth below should be read in conjunction with our Consolidated Financial Statements and notes thereto and “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” appearing elsewhere in this report.
−Removed: Year Ended September 30,
−Removed: (In thousands, except per share data)
−Removed: Operating income (loss)
−Removed: Income (loss) from continuing operations
−Removed: Income (loss) from discontinued operations, net of tax
−Removed: Net income (loss) attributable to Brooks Automation, Inc.
−Removed: Basic net income (loss) per share attributable to Brooks Automation, Inc.
−Removed: common stockholders:
−Removed: Income (loss) from continuing operations
−Removed: Income (loss) from discontinued operations, net of tax
−Removed: Basic net income (loss) per share attributable to Brooks Automation, Inc.
−Removed: Diluted net income (loss) per share attributable to Brooks Automation, Inc.
−Removed: common stockholders:
−Removed: Income (loss) from continuing operations
−Removed: Income (loss) from discontinued operations, net of tax
−Removed: Diluted net income (loss) per share attributable to Brooks Automation, Inc.
−Removed: Dividend declared per share
−Removed: As of September 30,
−Removed: (In thousands)
−Removed: Cash and cash equivalents and marketable securities
−Removed: Working capital (3)(5)
−Removed: Year Ended September 30, 2020
−Removed: (In thousands, except per share data)
−Removed: Operating income
−Removed: Net income attributable to Brooks Automation, Inc.
−Removed: Basic net income per share
−Removed: Diluted net income per share
−Removed: Year Ended September 30, 2019
−Removed: (In thousands, except per share data)
−Removed: Operating income
−Removed: Net income attributable to Brooks Automation, Inc.
−Removed: Basic net income per share
−Removed: Diluted net income per share
−Removed: (1) We make acquisitions from time to time and the selected financial data includes the operation results from these acquisitions in the results of operations from the dates of the acquisitions.
−Removed: Please refer to Note 4, “Acquisitions” to our Consolidated Financial Statements for additional information.
−Removed: (2) Operating income (loss) and net income (loss) includes a charge of $76.5 million during fiscal year 2016 related to an additional valuation allowance against our U.S.
−Removed: net deferred tax assets and a benefit of $77.2 million during fiscal year 2018 due to the partial reversal of the valuation allowance against U.S.
−Removed: net deferred tax assets.
−Removed: Please refer to Note 12, “Income Taxes” to our Consolidated Financial Statements for additional information.
−Removed: (3) The calculation of working capital excludes "Cash and cash equivalents"
−Removed: and "Marketable securities”.
−Removed: (4) On August 27, 2018, we entered into an agreement to sell our semiconductor cryogenics business.
−Removed: We determined that the semiconductor cryogenics business met the criteria of being reported as a discontinued operation as of September 30, 2018.
−Removed: As a result, the selected financial data presented for current period and prior periods have been revised to reflect the discontinued operation classification.
−Removed: Please refer to Note 3, “Discontinued Operations” to our Consolidated Financial Statements for additional information.
−Removed: The sale was completed in the fourth quarter of fiscal year 2019.
−Removed: Net income attributable to Brooks Automation, Inc.
−Removed: for the fourth quarter and full fiscal year of 2019 includes the net gain on the sale of the business of $408.6 million.
−Removed: (5) In connection with the closing of the sale of the semiconductor cryogenics business in the fourth quarter of fiscal 2019, we recorded accrued taxes payable of approximately $95 million as of September 30, 2019, which reduce our working capital for fiscal year 2019.
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.